Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.

This study makes the fundamental discovery of the first natural animal rhodopsin that uses a chloride ion instead of an amino acid side chain as a counterion. Using a combination of biochemical and ...

A portion of the Bourse building next to Independence Mall is being converted from office space and a food hall into a restaurant and a hotel. Expand to read more Paul Schwedelson / Philadelphia ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our ...

Bell & Ross has unveiled its latest timepiece, the BR-03 Astro. Designed to evoke the spirit of space exploration, the watch features the Earth, Moon, and Mars traveling across its dial ...

// Altere Linha 85 do arquivo config/app.php para: 'locale' => 'pt_BR' // Para versões >= 11.x altere a linha 8 do arquivo .env APP_LOCALE=pt_BR ...